# A Clinical Trial to Assess the Elixir Medical LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter

> **NCT05828173** · NA · COMPLETED · sponsor: **Elixir Medical Corporation** · enrollment: 60 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter (LithiX Coronary HCIVLC; LithiX)

## Key facts

- **NCT ID:** NCT05828173
- **Lead sponsor:** Elixir Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-27
- **Primary completion:** 2024-03-29
- **Final completion:** 2024-09-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05828173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05828173, "A Clinical Trial to Assess the Elixir Medical LithiX Coronary Hertzian Contact Intravascular Lithotripsy Catheter". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05828173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*